Toxic multinodular goiter primary prevention: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
 
(4 intermediate revisions by the same user not shown)
Line 4: Line 4:


==Overview==
==Overview==
*There are no established measures for the primary prevention of [disease name].
Effective measures for the primary prevention of toxic multinodular goiter include mainly the adequate [[iodin]]e intake, [[smoking cessation]] and also by maintaining normal intake of [[iron]] and [[vitamin A]].
*There are no available vaccines against [disease name].
OR
*Effective measures for the primary prevention of [disease name] include [measure1], [measure2], and [measure3].
*[Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include [strategy 1], [strategy 2], and [strategy 3].


==Primary Prevention==
==Primary Prevention==
*There are no established measures for the primary prevention of [disease name].
*Effective measures for the primary prevention of toxic multinodular goiter include:<ref name="pmid9019982">{{cite journal |vauthors=Pinchera A, Aghini-Lombardi F, Antonangeli L, Vitti P |title=[Multinodular goiter. Epidemiology and prevention] |language=Italian |journal=Ann Ital Chir |volume=67 |issue=3 |pages=317–25 |year=1996 |pmid=9019982 |doi= |url=}}</ref>
*There are no available vaccines against [disease name].
**Adequate [[iodine]] intake
OR
**[[Smoking cessation]]
*Effective measures for the primary prevention of [disease name] include:
**Normal level [[iron]]
**[measure1]
**Adequate intake of [[vitamin A]]
**[measure2]
**[measure3]
OR
*[Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include:
**[strategy 1]
**[strategy 2]
**[strategy 3]
 


==References==
==References==

Latest revision as of 13:44, 10 October 2017

Toxic multinodular goiter Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Toxic multinodular goiter from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Toxic multinodular goiter primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Toxic multinodular goiter primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Toxic multinodular goiter primary prevention

CDC on Toxic multinodular goiter primary prevention

Toxic multinodular goiter primary prevention in the news

Blogs on Toxic multinodular goiter primary prevention

Directions to Hospitals Treating Toxic multinodular goiter

Risk calculators and risk factors for Toxic multinodular goiter primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Effective measures for the primary prevention of toxic multinodular goiter include mainly the adequate iodine intake, smoking cessation and also by maintaining normal intake of iron and vitamin A.

Primary Prevention

References

  1. ↑ Pinchera A, Aghini-Lombardi F, Antonangeli L, Vitti P (1996). "[Multinodular goiter. Epidemiology and prevention]". Ann Ital Chir (in Italian). 67 (3): 317–25. PMID 9019982.

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Toxic_multinodular_goiter_primary_prevention&oldid=1372260"